Blastic plasmacytoid dendritic cell neoplasm previously called CD4+CD56+ haematodermic neoplasm or blastic NK cell lymphoma is a rare and clinically aggressive hematologic malignancy, derived from plasmacytoid dendritic cells. It is characterized by a skin tropism and co-expression of CD4 and CD56. We report the case of a 57 year old man who had lesions papulonulaires back and lower limbs associated with multiple lymph nodes. The diagnosis was made by histological examination and immunohistochemistry
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a neoplasm derived from precursors of plasma...
CD4+/CD56+ hematodermic neoplasm, formerly known as blastic NK cell lymphoma, is a rare and aggressi...
CD56-positive (CD56+) lymphomas, characterized by the expression of the neural cell adhesion molecul...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), also known as CD4+/CD56+ hematodermic neoplasm...
Blastic plasmacytoid dendritic cell neoplasm (a.k.a. NK cell lymphoma, CD4+CD56+ haematodermic neopl...
This is a publisher's version of an article published in Haematologica 2006 published by European He...
Plasmacytoid dendritic cell neoplasms are aggressive and rare hematologic malignancies characterized...
A blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a cutaneous lymphoma derived from a plasma...
Blastic plasmacytoid dendritic cell neoplasm is a rare hematologic neoplasm originating from plasmac...
Blastic plasmacytoid dendritic cell tumor is a rare, highly aggressive systemic neoplasm for which e...
Although the neoplasm of relatively mature type pDC was recently reported, that of pDC-precursor has...
AbstractBlastic natural killer (NK)-cell lymphoma is a clinically aggressive hemato-logic neoplasm w...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive, rare malignancy. Exact incide...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare malignancy with skin tropism. The ent...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a distinct and rare neoplastic entity and wa...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a neoplasm derived from precursors of plasma...
CD4+/CD56+ hematodermic neoplasm, formerly known as blastic NK cell lymphoma, is a rare and aggressi...
CD56-positive (CD56+) lymphomas, characterized by the expression of the neural cell adhesion molecul...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), also known as CD4+/CD56+ hematodermic neoplasm...
Blastic plasmacytoid dendritic cell neoplasm (a.k.a. NK cell lymphoma, CD4+CD56+ haematodermic neopl...
This is a publisher's version of an article published in Haematologica 2006 published by European He...
Plasmacytoid dendritic cell neoplasms are aggressive and rare hematologic malignancies characterized...
A blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a cutaneous lymphoma derived from a plasma...
Blastic plasmacytoid dendritic cell neoplasm is a rare hematologic neoplasm originating from plasmac...
Blastic plasmacytoid dendritic cell tumor is a rare, highly aggressive systemic neoplasm for which e...
Although the neoplasm of relatively mature type pDC was recently reported, that of pDC-precursor has...
AbstractBlastic natural killer (NK)-cell lymphoma is a clinically aggressive hemato-logic neoplasm w...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive, rare malignancy. Exact incide...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare malignancy with skin tropism. The ent...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a distinct and rare neoplastic entity and wa...
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a neoplasm derived from precursors of plasma...
CD4+/CD56+ hematodermic neoplasm, formerly known as blastic NK cell lymphoma, is a rare and aggressi...
CD56-positive (CD56+) lymphomas, characterized by the expression of the neural cell adhesion molecul...